Skip to main content
Bavarian Nordic logo

Bavarian Nordic — Investor Relations & Filings

Ticker · BAVA ISIN · DK0015998017 LEI · 2138006JCDVYIN6INP51 CO Manufacturing
Open in API
Filings indexed 2,297 across all filing types
Latest filing 2024-09-26 Earnings Release
Country DK Denmark
Listing CO BAVA

About Bavarian Nordic

https://www.bavarian-nordic.com/

Bavarian Nordic is a fully integrated biotechnology company specializing in the research, development, manufacturing, and commercialization of life-saving vaccines. The company's portfolio targets infectious diseases, including vaccines for Mpox, rabies, and typhoid. It is a leading global provider of travel vaccines and serves as a key partner for governments and international organizations in addressing public health preparedness needs.

Recent filings

Filing Released Lang Actions
Bavarian Nordic Upgrades its Financial Guidance for 2024
Earnings Release Classification · 95% confidence The document is a short announcement (under 4,000 characters) titled 'Bavarian Nordic Upgrades its Financial Guidance for 2024'. It provides updated revenue and EBITDA projections for the fiscal year 2024. While it contains financial figures, it is an initial announcement of guidance changes rather than a full quarterly or annual report. Per the 'Menu vs Meal' rule, this is a regulatory announcement regarding financial guidance updates, which fits best under the Earnings Release (ER) category as it details key financial highlights and guidance revisions. FY 2024
2024-09-26 Danish
Environmental & Social Information 2024
Environmental & Social Information Classification · 99% confidence The document is titled "Selskabsmeddelelse" (Company Announcement) and details a specific contract award of USD 63 million from BARDA (a US government agency) for the production and delivery of smallpox/mpox vaccines. This type of announcement, which communicates a significant business event, contract, or financial update outside of the regular periodic reporting cycle (like 10-K or IR), typically falls under a general regulatory announcement or a specific financing/contract update. Given the content focuses on a major contract win and production schedule, it is a significant corporate event announcement. It is not a full Annual Report (10-K), an Interim Report (IR), an Earnings Release (ER), or a Call Transcript (CT). It is a specific announcement regarding a contract, which aligns best with a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the focus was purely on the funding mechanism, but RNS serves as the best general category for material, non-periodic corporate news releases in this context, especially since it is a 'Company Announcement'. Since the document is a formal press release announcing a material event (a contract), RNS is the most appropriate general classification for such regulatory disclosures not covered by other specific codes.
2024-09-24 Danish
Regulatory Filings 2024
Regulatory Filings Classification · 100% confidence The document is titled "Company Announcement" and details a specific contract award from BARDA (U.S. Government) for vaccine production and supply. It is a press release format announcing a significant business event (a contract/order) rather than a mandatory regulatory filing like a 10-K, an earnings report (ER), or a detailed financial statement (IR). Since it announces a major business development, contract, or financing activity, it fits best under Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Given the focus is on a large contract award that impacts future revenue and operations, and it is not a standard financial report, it is most closely aligned with a significant business update. However, none of the definitions perfectly capture a 'Contract Award Announcement'. Comparing the options: It is not an ER (too detailed), not an IR (not a periodic financial report), and not a CT. It is a specific business update. Since it involves a large monetary award and supply commitment, it relates to the company's financial structure and future business, making 'CAP' (Capital/Financing Update) a plausible fit if interpreted broadly as a major funding/contract event, but 'RNS' (Regulatory Filings/General Announcement) is often used for press releases announcing specific, non-standard operational news like this. Given the options, and recognizing this is a press release announcing a major contract, it is best classified as a general regulatory/company announcement that doesn't fit the specific financial report codes. I will use RNS as the best fit for a non-standard, material company announcement that isn't a core financial report or management change.
2024-09-24 English
Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines
Regulatory Filings Classification · 95% confidence The document is a corporate announcement from Bavarian Nordic regarding a new contract with the U.S. government (BARDA) for vaccine production. While it provides details about the contract, it is structured as a press release/regulatory announcement (Selskabsmeddelelse nr. 32 / 2024) and includes a link to an attached file. According to the 'Menu vs Meal' rule, since this is a short announcement of a contract award and includes a link to the full document, it is classified as a Regulatory Filing (RNS).
2024-09-24 Danish
Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines
Regulatory Filings Classification · 95% confidence The document is a press release announcing a new contract award from the U.S. government for vaccine production. While it mentions an attachment, the text itself provides the core details of the business development (a $63 million contract). This type of corporate announcement regarding new business, contracts, or operational updates is best classified as a Regulatory Filing (RNS) as it serves as a general corporate announcement that does not fit into more specific categories like M&A or financial results.
2024-09-24 Danish
Regulatory Filings 2024
Regulatory Filings Classification · 96% confidence The document is titled "Company Announcement" and details an agreement between Bavarian Nordic and Gavi for securing Mpox vaccines. It includes key highlights, quotes from CEOs, and background information on the vaccine and the involved organizations. This format strongly suggests an initial, high-level release of significant corporate news, rather than a comprehensive periodic report (like 10-K or IR) or a transcript. It fits the definition of an Earnings Release (ER) in structure, although the content is about a specific transaction/partnership rather than quarterly earnings. However, since it is a formal announcement of a major business event (a significant purchase agreement) and not a regulatory filing like a 10-K or a general regulatory notice (RNS), and given the options, it most closely resembles an Earnings Release (ER) in its function as a primary, time-sensitive corporate disclosure, or potentially a Regulatory Filing (RNS) if ER is strictly reserved for financial results. Given the context of major corporate news dissemination, ER is often used for significant operational announcements when a dedicated category doesn't exist. Since this is a major partnership/supply agreement announcement, and not a standard financial results release, the most appropriate general category for a significant, non-standard corporate announcement that isn't a specific report or transaction filing is RNS (Regulatory Filings/General Announcement). However, if we interpret 'Earnings Release' broadly as 'Key Corporate News Release', ER might apply. Given the specific nature of the announcement (a major supply agreement), and lacking a specific 'Partnership Announcement' code, RNS is the safest fallback for a significant, non-periodic announcement. Upon review, this is a press release announcing a major business development, which often falls under RNS if ER is strictly for financial performance reporting. I will classify it as RNS as it is a general company announcement of a material event.
2024-09-18 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.